AFP and nongerminomatous germ cell tumor: Management of these patients is supported by monitoring tumour markers such as alpha fetoprotein (AFP) and human chorionic gonadotrophin (HCG), which are elevated in patients with metastatic NSGCT in around two-thirds of cases [2].